Status and phase
Conditions
Treatments
About
The investigators set out to evaluate the effects of the traditional Chinese medicinal mixture under the brand name YangXinShi (YXS) on the prognosis in patients with chronic heart failure when it is combined with the optimal combination drug treatment of heart failure.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
80 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
haoren wang, M.D., M.S.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal